Visual impairment and medication safety: a protocol for a scoping review

The number of individuals with a visual impairment in the UK was estimated a few years ago to be around 1.8 million. People can be visually impaired from birth, childhood, early adulthood or later in life. Those with visual impairment are subject to health inequities and increased risk for patient s...

Full description

Saved in:
Bibliographic Details
Published in:Systematic reviews 2021-09, Vol.10 (1), p.248-6, Article 248
Main Authors: Giles, Sally J, Panagioti, Maria, Riste, Lisa, Cheraghi-Sohi, Sudeh, Lewis, Penny, Adeyemi, Isabel, Davies, Karen, Morris, Rebecca, Phipps, Denham, Dickenson, Christine, Ashcroft, Darren, Sanders, Caroline
Format: Article
Language:English
Subjects:
Adult
Blindness
Child
Drug dosages
Humans
Medication Errors
Medication safety
Patient Safety
Population
Protocol
Research Design
Review Literature as Topic
Systematic review
Vision Disorders - chemically induced
Visual impairment
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The number of individuals with a visual impairment in the UK was estimated a few years ago to be around 1.8 million. People can be visually impaired from birth, childhood, early adulthood or later in life. Those with visual impairment are subject to health inequities and increased risk for patient safety incidents in comparison to the general population. They are also known to be at an increased risk of experiencing medication errors compared to those without visual impairment. In view of this, this review aims to understand the issues of medication safety for VI people. Four electronic bibliographic databases will be searched: MEDLINE, Embase, PsycInfo and CINAHL. Our search strategy will include search combinations of two key blocks of terms. Studies will not be excluded based on design. Included studies will be empirical studies. They will include studies that relate to both medication safety and visual impairment. Two reviewers (SG and LR) will screen all the titles and abstracts. SG, LR, RM, SCS and PL will perform study selection and data extraction using standard forms. Disagreements will be resolved through discussion or third party adjudication. Data to be collected will include study characteristics (year, objective, research method, setting, country), participant characteristics (number, age, gender, diagnoses), medication safety incident type and characteristics. The review will summarise the literature relating to medication safety and visual impairment.
ISSN:2046-4053
2046-4053
DOI:10.1186/s13643-021-01800-8